|Bid||252.60 x 1300|
|Ask||258.11 x 800|
|Day's range||250.00 - 253.56|
|52-week range||215.96 - 304.86|
|Beta (5Y monthly)||1.66|
|PE ratio (TTM)||12.47|
|Earnings date||25 Jan 2024 - 29 Jan 2024|
|Forward dividend & yield||2.40 (0.95%)|
|Ex-dividend date||13 Dec 2023|
|1y target est||281.75|
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Warren Buffett, the man widely regarded as the greatest contemporary investor, is famous for saying that his favorite interesting period is "forever." To do so, turning to the healthcare industry is a good idea -- since medical care is, and will always be, in demand. Vertex Pharmaceuticals has an excellent track record.